Dr. Murakami is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4921 Parkview Pl
# Dv
Saint Louis, MO 63110Phone+1 314-362-5365Fax+1 314-362-5470
Education & Training
Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2015 - 2019
Icahn School of Medicine at Mount Sinai/Beth IsraelResidency, Internal Medicine, 2012 - 2015
Graduate School of Medicine and Faculty of Medicine, The University of TokyoClass of 2010
Certifications & Licensure
IL State Medical License 2024 - 2026
MA State Medical License 2013 - 2025
MO State Medical License 2024 - 2025
NH State Medical License 2024 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Publications & Presentations
PubMed
- 78 citationsTherapeutic advances in COVID-19.Naoka Murakami, Robert Hayden, Thomas Hills, Hanny Al-Samkari, Jonathan Casey
Nature Reviews. Nephrology. 2023-01-01 - 13 citationsCemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma.Glenn J Hanna, Harita Dharanesswaran, Anita Giobbie-Hurder, John J Harran, Zixi Liao
Journal of Clinical Oncology. 2024-03-20 - 97 citationsA multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplantNaoka Murakami, Patrick M. Mulvaney, Melissa J. Danesh, Ala Abudayyeh, Adi Diab
Kidney International. 2021-07-01
Press Mentions
- Renal Allografts at Risk After ICIs for Subsequent CancerOctober 29th, 2020
Many Dialysis Patients Ill-Prepared for Emergencies, Study SaysFebruary 10th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
